IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA adds warning to J&J vaccine for possible link to rare neurological disorder


The Food and Drug Administration is adding a warning label to the Johnson & Johnson Covid-19 vaccine following reports of 100 cases of Guillain-Barré syndrome in vaccine recipients.